# Global Research Trends and Hotspots in Cerebral Small Vessel Disease‐Related Cognitive Impairment: A Bibliometric Analysis (2001–2024)

**Authors:** Kuihua Wang, Xiaohui Ji, Hui Li, Xiaoyang Wang, Xiaoyue Jin, YanJun Lin, Qiao Wang, Haizhen Xu, Jianxin Ye, Xiaoping Cui, Yonghui Liang

PMC · DOI: 10.1002/brb3.71167 · Brain and Behavior · 2026-01-25

## TL;DR

This study maps global research trends in cerebral small vessel disease-related cognitive impairment from 2001 to 2024, identifying key areas and contributors.

## Contribution

The study provides the first comprehensive bibliometric analysis of CSVD-related cognitive impairment research trends and hotspots.

## Key findings

- Three research phases were identified: foundational (2001–2010), developmental (2011–2018), and accelerated (2019–2024).
- China led in publications, while the Netherlands showed the strongest academic influence.
- Four research clusters emerged: pathophysiology, neuroimaging, clinical assessment, and therapeutic interventions.

## Abstract

Cerebral small vessel disease (CSVD) is a significant contributor to cognitive impairment (CI). Research on CSVD‐CI has gained prominence; however, comprehensive bibliometric analysis of the global research landscape in this area is currently lacking. This study aims to address this gap by conducting a thorough bibliometric analysis to identify research hotspots and emerging trends.

We retrieved relevant literature published from 2001 to 2024 from the web of science (WoS) core collection. using VOSviewer, CiteSpace, R, and Origin 2022, we performed bibliometric and network visualization analyses to examine publication trends, geographical distribution, institutional collaborations, journal metrics, citation patterns, author contributions, co‐citation networks, and keyword co‐occurrence.

Three distinct phases were identified: foundational (2001–2010), developmental (2011–2018), and accelerated (2019–2024). The United States exhibited the highest citation impact, whereas China reported the highest number of publications. The journals “neurology” and “stroke” emerged as the leading publications. Four major research clusters were revealed: pathophysiological mechanisms (neuroinflammation and oxidative stress), neuroimaging biomarkers (white matter hyperintensities (WMH) and cerebral micro bleeds), clinical manifestations and cognitive assessment, and therapeutic interventions. Emerging trends included blood‐brain barrier (BBB) dysfunction, neurovascular coupling, and innovative therapies.

This bibliometric study sheds light on the research hotspots and trends in CSVD‐CI over the past two decades, assisting researchers in identifying key focus areas and exploring advancements in this domain.

This bibliometric study systematically analyzed 1074 publications in the field of CSVD‐CI from 2001 to 2024. The research reveals three evolutionary phases and identifies four core research clusters: pathophysiological mechanisms, neuroimaging biomarkers, clinical assessment, and therapeutic interventions. China contributed the highest number of publications, while the Netherlands demonstrated the strongest academic influence. The analysis clarifies the evolution of research hotspots and international collaboration patterns, offering comprehensive guidance for future research in this field.

## Full-text entities

- **Diseases:** amyloid angiopathy (MESH:C538248), Leukoencephalopathy (MESH:D056784), sleep apnea (MESH:D012891), dementia (MESH:D003704), neuronal damage (MESH:D009410), non-hereditary microangiopathies (MESH:D030342), cerebral hemorrhage (MESH:D002543), hyperhomocysteinemia (MESH:D020138), CSVD (MESH:D059345), Cerebral Autosomal Dominant Arteriopathy (MESH:D020943), Neurological Diseases (MESH:D020271), deficits in attention, memory, and executive function (MESH:D001289), chronic cerebral ischemia (MESH:D002545), Stroke (MESH:D020521), hyperlipidemia (MESH:D006949), neuroinflammation (MESH:D000090862), cerebrovascular disorder (MESH:D002561), cerebral microbleeds (MESH:D002547), CAA (MESH:D016657), neurodegenerative diseases (MESH:D019636), hypertension (MESH:D006973), Subcortical Infarcts (MESH:D002544), multiple sclerosis (MESH:D009103), cerebral micro bleeds (MESH:C536681), leukoaraiosis (MESH:D049292), synaptic dysfunction (MESH:C536122), cerebral microvascular disease (MESH:D017566), Sleep fragmentation (MESH:D012892), vascular endothelial dysfunction (MESH:D014652), dysfunction (MESH:D006331), insomnia (MESH:D007319), CADASIL (MESH:D046589), BBB dysfunction (MESH:C536830), mood disorders (MESH:D019964), neurovascular unit dysfunction (MESH:D013901), gait disturbances (MESH:D020233), MCI (MESH:D060825), vascular pathologies (MESH:D005598), diabetes (MESH:D003920), disorder (MESH:D009358), neurological disorders (MESH:D009461), alzheimer's (MESH:D000544), CI (MESH:D003072), vascular dementia (MESH:D015140), Sleep Disorders (MESH:D012893)
- **Chemicals:** CSVD-CI (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12832104/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12832104/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12832104/full.md

---
Source: https://tomesphere.com/paper/PMC12832104